Gilead Sciences Announces Second Quarter and First Half 2020 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq reaches record high close, AI stocks rally
- Meta AI agent triggers heavy selloff in banks, insurers, and travel stocks
- Exclusive: SB Energy Nasdaq IPO moving forward as planned
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Gilead Sciences (GILD) Misses Q2 EPS by 34c; Guides In-Line
July 30, 2020 4:03 PM EDTGilead Sciences (NASDAQ: GILD) reported Q2 EPS of $1.11, $0.34 worse than the analyst estimate of $1.45. Revenue for the quarter came in at $5.1 billion versus the consensus estimate of $5.31 billion.
GUIDANCE:
Gilead Sciences sees FY2020 EPS of $6.25-$7.65, versus the consensus of... More
